Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes

doi:10.5493/wjem.v14.i1.89320

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3100)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

HTML

1489

Figures (1-3)

254

Tables (1-1)

259

Sum=2098

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

171

Download

356

Sum=527

Publishing Process of This Article

Item

Count

Browse

106

Download

256

Sum=362

Mar 20, 2024 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Exp Med. Mar 20, 2024; 14(1): 89320
Published online Mar 20, 2024. doi: 10.5493/wjem.v14.i1.89320

Full Size Figure Download Figure

Figure 2 The molecule of proinsulin with its components.

Citation: Milionis C, Ilias I, Lekkou A, Venaki E, Koukkou E. Future clinical prospects of C-peptide testing in the early diagnosis of gestational diabetes. World J Exp Med 2024; 14(1): 89320
URL: https://www.wjgnet.com/2220-315x/full/v14/i1/89320.htm
DOI: https://dx.doi.org/10.5493/wjem.v14.i1.89320